SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-044131
Filing Date
2021-08-13
Accepted
2021-08-13 06:06:13
Documents
61
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pmvp-10q_20210630.htm   iXBRL 10-Q 2067258
2 EX-31.1 pmvp-ex311_7.htm EX-31.1 19916
3 EX-31.2 pmvp-ex312_8.htm EX-31.2 20473
4 EX-32.1 pmvp-ex321_6.htm EX-32.1 9623
5 EX-32.2 pmvp-ex322_9.htm EX-32.2 9851
  Complete submission text file 0001564590-21-044131.txt   6821025

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA pmvp-20210630.xsd EX-101.SCH 45600
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pmvp-20210630_cal.xml EX-101.CAL 39884
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pmvp-20210630_def.xml EX-101.DEF 138806
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmvp-20210630_lab.xml EX-101.LAB 353076
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmvp-20210630_pre.xml EX-101.PRE 268297
11 EXTRACTED XBRL INSTANCE DOCUMENT pmvp-10q_20210630_htm.xml XML 1180414
Mailing Address 8 CLARKE DRIVE CRANBURY NJ 08512
Business Address 8 CLARKE DRIVE CRANBURY NJ 08512 (609) 642-6664
PMV Pharmaceuticals, Inc. (Filer) CIK: 0001699382 (see all company filings)

IRS No.: 463218129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39539 | Film No.: 211169595
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences